Actuate Therapeutics IncACTUNASDAQ
Loading
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+6.4%/yr
Annual compound
Percentile
P33
Within normal range
vs 3Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $24.37M | -3.2% |
| 2024 | $25.16M | +0.7% |
| 2023 | $24.97M | +23.6% |
| 2022 | $20.21M | - |